DDIS-26. HIGH-THROUGHPUT DRUG SCREENING OF MENINGIOMAS IDENTIFIES HDAC INHIBITORS AS PROMISING TARGETS ACROSS GRADES

Meningiomas are a common central nervous system (CNS) tumor, accounting for one third of CNS neoplasms. To date, no FDA approved pharmacotherapy exists for meningiomas. In an effort to identify potential treatments for meningiomas we created a culture system that allows us to grow and screen tumors...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Tatman, Philip, Fringuello, Anthony, Wroblewski, Teddy, Scherer, Sam, Foreman, William, Ryan Ormond, D, Damek, Denise, Lillehei, Kevin, Jensen, Randy, Graner, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Drug Discovery
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847367/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.277
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller